The favorable tumor marker decline was defined as tumor marker normalization within 9 weeks for AFP and 6 weeks for β-HCG, which correspond to three cycles and two cycles of chemotherapy treatment, respectively [40]. This evidence concerns the gene AFP and neoplasm.